Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02386111
Title A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Celldex Therapeutics
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35294 United States Details
UC Davis Comprehensive Cancer Center Sacramento California 95817 United States Details
UCSF Helen Diller Comprehensive Cancer Center San Francisco California 94158 United States Details
George Washington University-Medical Faculty Associates Washington District of Columbia 20037 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Nebraska Cancer Specialists Omaha Nebraska 68130 United States Details
Mount Sinai Medical Center New York New York 10029 United States Details
Thomas Jefferson University Philadelphia Pennsylvania 19107 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field